Literature DB >> 27313776

Melanoma educates mesenchymal stromal cells towards vasculogenic mimicry.

Amalia Vartanian1, Saida Karshieva2, Vladislav Dombrovsky1, Alexander Belyavsky2.   

Abstract

Accumulating evidence suggests that mesenchymal stromal cells (MSCs) are recruited to the tumor, and promote tumor development and growth. The present study was performed to investigate the communication between aggressive melanoma and MSCs in vasculogenic mimicry (VM). Normal human MSCs plated on Matrigel were unable to form capillary-like structures (CLSs). By contrast, MSCs co-cultured with aggressive melanoma cell lines, namely, Mel Cher, Mel Kor and Mel P, generated CLSs. Significantly, MSCs co-cultured with poorly aggressive melanoma cells, namely, Mel Me, failed to form CLSs. To identify factors responsible for VM, the effects of vascular endothelial growth factor A (VEGFA), pro-epidermal growth factor, basic fibroblast growth factor and stromal cell-derived factor 1α on the formation of CLSs by MSCs were tested. VM was induced by the addition of VEGFA, whereas other cytokines were inefficient. To confirm the hypothesis that aggressive tumor cells can increase the vasculogenic ability of MSCs, a standard B16/F10 mouse melanoma test system was used. MSCs isolated from the adipose tissues of C57BL/6 mice with melanoma formed a vascular-like network on Matrigel, whereas MSCs from healthy mice failed to form such structures. This study provides the first direct evidence that melanoma tumors educate MSCs to engage in VM. The education may occur distantly. These findings offer promise for novel therapeutic directions in the treatment of metastatic melanoma.

Entities:  

Keywords:  C57BL/6 mice; melanoma; mesenchymal stromal cells; vasculogenic mimicry

Year:  2016        PMID: 27313776      PMCID: PMC4888129          DOI: 10.3892/ol.2016.4523

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  22 in total

1.  Mast cells contribute to vasculogenic mimicry in multiple myeloma.

Authors:  Beatrice Nico; Domenica Mangieri; Enrico Crivellato; Angelo Vacca; Domenico Ribatti
Journal:  Stem Cells Dev       Date:  2008-02       Impact factor: 3.272

2.  Hypoxia influences vasculogenic mimicry channel formation and tumor invasion-related protein expression in melanoma.

Authors:  Baocun Sun; Danfang Zhang; Shiwu Zhang; Wenzhi Zhang; Hua Guo; Xiulan Zhao
Journal:  Cancer Lett       Date:  2006-09-25       Impact factor: 8.679

3.  Tumor stromal-derived factor-1 recruits vascular progenitors to mitotic neovasculature, where microenvironment influences their differentiated phenotypes.

Authors:  Manish Aghi; Kenneth S Cohen; Rachael J Klein; David T Scadden; E Antonio Chiocca
Journal:  Cancer Res       Date:  2006-09-15       Impact factor: 12.701

4.  Stromal cell-derived factor-1/CXCR4 signaling modifies the capillary-like organization of human embryonic stem cell-derived endothelium in vitro.

Authors:  Tong Chen; Hao Bai; Ying Shao; Melanie Arzigian; Viktor Janzen; Eyal Attar; Yi Xie; David T Scadden; Zack Z Wang
Journal:  Stem Cells       Date:  2006-10-12       Impact factor: 6.277

5.  Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry.

Authors:  A J Maniotis; R Folberg; A Hess; E A Seftor; L M Gardner; J Pe'er; J M Trent; P S Meltzer; M J Hendrix
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

6.  [Melanoma cell lines as the basis for antitumor vaccine preparation].

Authors:  I N Mikhaĭlova; M I Lukashina; A Iu Baryshnikov; L F Morozova; O S Burova; T N Palkina; A M Kozlov; V A Golubeva; E A Cheremushkin; M B Doroshenko; L V Demidov; S L Kiselev; S S Larin; G P Georgiev
Journal:  Vestn Ross Akad Med Nauk       Date:  2005

7.  Vasculogenic mimicry by bone marrow macrophages in patients with multiple myeloma.

Authors:  C Scavelli; B Nico; T Cirulli; R Ria; G Di Pietro; D Mangieri; A Bacigalupo; G Mangialardi; A M L Coluccia; T Caravita; S Molica; D Ribatti; F Dammacco; A Vacca
Journal:  Oncogene       Date:  2007-07-30       Impact factor: 9.867

8.  Vasculogenic mimicry of acute leukemic bone marrow stromal cells.

Authors:  P Mirshahi; A Rafii; L Vincent; A Berthaut; R Varin; G Kalantar; C Marzac; O A Calandini; J-P Marie; C Soria; J Soria; M Mirshahi
Journal:  Leukemia       Date:  2009-04-02       Impact factor: 11.528

9.  Functional significance of VEGF-a in human ovarian carcinoma: role in vasculogenic mimicry.

Authors:  Jun-Yan Wang; Tao Sun; Xiu-Lan Zhao; Shi-Wu Zhang; Dan-Fang Zhang; Qiang Gu; Xing-Hui Wang; Nan Zhao; Shuo Qie; Bao-Cun Sun
Journal:  Cancer Biol Ther       Date:  2008-05-20       Impact factor: 4.742

Review 10.  Tumor microenvironment: bone marrow-mesenchymal stem cells as key players.

Authors:  Pedro Barcellos-de-Souza; Valentina Gori; Franco Bambi; Paola Chiarugi
Journal:  Biochim Biophys Acta       Date:  2013-10-29
View more
  8 in total

1.  Expression of STAT3 and vasculogenic mimicry in gallbladder carcinoma promotes invasion and metastasis.

Authors:  Hongbing Zhou; Yin Yuan; Haixin Qian
Journal:  Exp Ther Med       Date:  2021-05-09       Impact factor: 2.447

2.  PGC-1α induced mitochondrial biogenesis in stromal cells underpins mitochondrial transfer to melanoma.

Authors:  Prakrit R Kumar; Mona Saad; Charlotte Hellmich; Jayna J Mistry; Jamie A Moore; Shannon Conway; Christopher J Morris; Kristian M Bowles; Marc D Moncrieff; Stuart A Rushworth
Journal:  Br J Cancer       Date:  2022-03-26       Impact factor: 9.075

Review 3.  Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma.

Authors:  Dhiraj Kumar; Mahadeo Gorain; Gautam Kundu; Gopal C Kundu
Journal:  Mol Cancer       Date:  2017-01-30       Impact factor: 27.401

Review 4.  Vasculogenic mimicry signaling revisited: focus on non-vascular VE-cadherin.

Authors:  Daniel Delgado-Bellido; Santiago Serrano-Saenz; Mónica Fernández-Cortés; F Javier Oliver
Journal:  Mol Cancer       Date:  2017-03-21       Impact factor: 27.401

Review 5.  Overview of advances in vasculogenic mimicry - a potential target for tumor therapy.

Authors:  Hong Ge; Hui Luo
Journal:  Cancer Manag Res       Date:  2018-08-02       Impact factor: 3.989

Review 6.  Mesenchymal stem cells in cancer therapy; the art of harnessing a foe to a friend.

Authors:  Mehdi Karimi-Shahri; Hossein Javid; Alireza Sharbaf Mashhad; Shaghayegh Yazdani; Seyed Isaac Hashemy
Journal:  Iran J Basic Med Sci       Date:  2021-10       Impact factor: 2.699

Review 7.  Concise Review: Cancer Cells, Cancer Stem Cells, and Mesenchymal Stem Cells: Influence in Cancer Development.

Authors:  Federica Papaccio; Francesca Paino; Tarik Regad; Gianpaolo Papaccio; Vincenzo Desiderio; Virginia Tirino
Journal:  Stem Cells Transl Med       Date:  2017-10-26       Impact factor: 6.940

Review 8.  Mitochondrial oxidative phosphorylation in cutaneous melanoma.

Authors:  Prakrit R Kumar; Jamie A Moore; Kristian M Bowles; Stuart A Rushworth; Marc D Moncrieff
Journal:  Br J Cancer       Date:  2020-11-18       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.